Problem Identification: Involvement in treatment decision making (TDM) is considered a key element of patient- and family-centered care and positively affects outcomes. However, for adolescents and young adults (AYAs) with cancer, little is known about the current state of knowledge about their...

Background: By using the body’s own protective system to fight cancer, immunotherapy is not only effective but also is associated with fewer side effects than chemotherapy. Objectives: This article provides an overview of four types of immunotherapy (monoclonal antibodies, chimeric antigen...

Objectives: To explore and estimate relationships among the elements of the symptom cluster in survivors of brain tumors aged 8–12 years during early survivorship. Sample & Setting: Child participants completed treatment at least six months and less than six years prior to enrollment at...

Problem Identification: Pediatric oncology phase 1 clinical trials (P1Ts) are essential to developing new anticancer therapies; however, they raise complex ethical concerns about balancing the need for this research with the well-being of participating children. The purpose of this integrative...